TITLE

In vitro migratory aberrancies of mesenchymal stem cells derived from multiple myeloma patients only partially modulated by bortezomib

AUTHOR(S)
Xinxin Xu; Jiao Yang; Yu Tang; Junxia Li; Yan Zhu; Hua Lu; Xiaoming Fei
PUB. DATE
November 2014
SOURCE
International Journal of Clinical & Experimental Medicine;2014, Vol. 7 Issue 10, p6705
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Recent studies indicated that bone marrow mesenchymal stem cells (BM-MSCs) derived from multiple myeloma (MM) patients were different from those of normal subjects in a variety of aspects. However, it is largely unknown whether BM-MSCs derived from MM patients display any aberrant chemotactic migration. To this aim, we compared the chemotactic migration of BM-MSCs derived from MM patients with those from normal subjects. Our results showed that BM-MSCs derived from MM patients migrated more vigorously to myeloma cell line. Furthermore, proteasome inhibitor bortezomib was showed to suppress chemotactic migration of BM-MSCs whatever their origins. However, although the chemotactic migration of BM-MSCs derived from MM patients to myeloma cell line was more significantly suppressed by bortezomib treatment, migration to SDF-1 or FBS of BM-MSCs was less compromised. Both SDF-1 and TNF-α enhanced phosphorylation of iκ-Bα in BM-MSCs. Although bortezomib significantly inhibited the iκ-Bα phosphorylation by SDF-1, it had little effect on iκ-Bα phosphorylation by TNF-α. Collectively, our results suggested that aberrant chemotactic migration of BM-MSCs derived from MM patients and the possible migration-regulatory role of bortezomib treatment.
ACCESSION #
99459205

 

Related Articles

  • Impacts of K562 cells towards activities of Toll-like receptor pathway of human mesenchymal stem cell-bone marrow. Zheng Xu; Jianmin Luo; Lin Yang; Xingzhe Wang; Yuxia Pan; Yintao Shang; Jingci Yang // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 6, p9320 

    The study aim was to investigate the impacts of K562 cells towards the activities of Toll-like receptor pathway of human mesenchymal stem cell-bone marrow (HMSC-bm). The in vitro co-culture of HMSC-bm and K562 cells was set as the experiment group (HMSC-bm + K562), the HMSC-bm cultured alone was...

  • Immune impairments in multiple myeloma bone marrow mesenchymal stromal cells. André, Thibaud; Najar, Mehdi; Stamatopoulos, Basile; Pieters, Karlien; Pradier, Olivier; Bron, Dominique; Meuleman, Nathalie; Lagneaux, Laurence // Cancer Immunology, Immunotherapy;Feb2015, Vol. 64 Issue 2, p213 

    In multiple myeloma (MM), bone marrow mesenchymal stromal cells (BM-MSCs) play an important role in pathogenesis and disease progression by supporting myeloma cell growth and immune escape. Previous studies have suggested that direct and indirect interactions between malignant cells and BM-MSCs...

  • Regulation effects of melatonin on bone marrow mesenchymal stem cell differentiation. Wang, Biao; Wen, Hao; Smith, Wanli; Hao, Dingjun; He, Baorong; Kong, Lingbo // Journal of Cellular Physiology;Feb2019, Vol. 234 Issue 2, p1008 

    Melatonin's therapeutic potential has been highly underestimated because its biological functional roles are diverse and relevant mechanisms are complicated. Among the numerous biological activities of melatonin, its regulatory effects on pluripotent mesenchymal stem cells (MSCs), which are...

  • CDCP1 Identifies a CD146 Negative Subset of Marrow Fibroblasts Involved with Cytokine Production. Iwata, Mineo; Torok-Storb, Beverly; Wayner, Elizabeth A.; Carter, William G. // PLoS ONE;Oct2014, Vol. 9 Issue 10, p1 

    In vitro expanded bone marrow stromal cells contain at least two populations of fibroblasts, a CD146/MCAM positive population, previously reported to be critical for establishing the stem cell niche and a CD146-negative population that expresses CUB domain-containing protein 1 (CDCP1)/CD318....

  • Absence of Kaposi's sarcoma-associated herpesvirus (KSHV) in bone marrow cells from Japanese myeloma patients. Harada, N; Hata, H; Matsuno, F; Sonoki, T; Kuribayashi, N; Matsuzaki, H; Mitsuya, H // Leukemia (08876924);Sep99, Vol. 13 Issue 9, p1465 

    Studies the absence of Kaposi's sarcoma-associated herpesvirus (KSHV) in bone marrow cells from Japanese myeloma patients. Significance of KSHV in multiple myeloma (MM); Correlation between the pathogenesis of MM and KSHV in Europe and the U.S.; Analysis of bone marrow mononuclear cells and...

  • Effect of Hydrostatic Pressure in The Presence of Staurosporine on Neurite Outgrowth in Mouse Bone Marrow Mesenchymal Stem Cells. Javanmard, F.; Azadbakht, M.; Zhaleh, H. // Cell Journal (Yakhteh);Summer 2013 Supplement 1, Vol. 15 Issue Sup 1, p49 

    Objective: Bone marrow mesenchymal stem cells (BMSCS) are pluripotent cells that can differentiate into many types of cell lines including; neural cells. Mechanical forces are an important factor on nerve regeneration. It also should be noted that the mechanical stimulation could induce not only...

  • Effect of substrate stiffness on the osteogenic differentiation of bone marrow stem cells and bone-derived cells. Witkowska‐Zimny, Malgorzata; Walenko, Katarzyna; Wrobel, Edyta; Mrowka, Piotr; Mikulska, Agnieszka; Przybylski, Jacek // Cell Biology International;6/1/2013, Vol. 37 Issue 6, p608 

    There is a profound dependence of cell behaviour on the stiffness of its microenvironment. To gain a better understanding of the regulation of cellular differentiation by mechanical cues, we investigated the influence of matrix stiffness ( E = 1.46 kPa and E = 26.12 kPa) on differentiated...

  • The Effect of Cartilage Tissue Extraction of 13 Days-Old Mouse Embryo on Differentiation of Bone Marrow Mesenchymal Stem Cells to Osteoblasts. Ramezani, M.; Khanbabaee, R.; Hojati, V. // Cell Journal (Yakhteh);Summer 2013 Supplement 1, Vol. 15 Issue Sup 1, p71 

    Objective: Mesenchymal stem cells (MSCs) are nonhematopoietic and multipotent cells, which during development are derived from cells with a mesenchymal origin. Also they have high proliferative potential in the long term and are able to differentiation into osteoblast, osteocyte, adipocyte and...

  • p53 Loss Increases the Osteogenic Differentiation of Bone Marrow Stromal Cells. He, Yunlong; de Castro, Luis F.; Shin, Min Hwa; Dubois, Wendy; Yang, Howard H.; Jiang, Shunlin; Mishra, Pravin J.; Ren, Ling; Gou, Hongfeng; Lal, Ashish; Khanna, Chand; Merlino, Glenn; Lee, Maxwell; Robey, Pamela G.; Huang, Jing // Stem Cells (Wiley-Blackwell);Apr2015, Vol. 33 Issue 4, p1304 

    The tumor suppressor, p53, plays a critical role in suppressing osteosarcoma. Bone marrow stromal cells (BMSCs, also known as bone marrow-derived mesenchymal stem cells) have been suggested to give rise to osteosarcomas. However, the role of p53 in BMSCs has not been extensively explored. Here,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics